Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients].
Rivero A, López-Cortés L, Castillo R, Verdejo J, García MA, Martínez-Marcos FJ, Díez F, Escribano JC, Canueto J, Lozano F, Pasquau J, Hernández JJ, Márquez M, Kindelán JM; Grupo Andaluz para el estudio de las Enfermedades Infecciosas (GAEI). Rivero A, et al. Among authors: kindelan jm. Enferm Infecc Microbiol Clin. 2007 May;25(5):305-10. doi: 10.1157/13102265. Enferm Infecc Microbiol Clin. 2007. PMID: 17504683 Clinical Trial. Spanish.
[Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy].
Rivero A, López-Cortés L, Castillo R, Lozano F, García MA, Díez F, Escribano JC, Canueto J, Pasquau J, Hernández JJ, Polo R, Martínez-Marcos FJ, Kindelán JM, Rey R; Grupo Andaluz para el estudio de las Enfermedades Infecciosas (GAEI). Rivero A, et al. Among authors: kindelan jm. Enferm Infecc Microbiol Clin. 2003 Jun-Jul;21(6):287-92. doi: 10.1016/s0213-005x(03)72942-5. Enferm Infecc Microbiol Clin. 2003. PMID: 12809582 Clinical Trial. Spanish.
[Use of rifampicin plus pyrazinamide for antituberculosis prophylaxis does not increase the risk of severe hepatotoxicity in HIV patients: meta-analysis of randomized controlled clinical trials].
Camacho A, Pérez-Camacho I, Rivero A, Natera C, García-Lázaro M, Castón JJ, Gallo M, Kindelán JM, Torre-Cisneros J. Camacho A, et al. Among authors: kindelan jm. Enferm Infecc Microbiol Clin. 2010 Apr;28(4):239-44. doi: 10.1016/j.eimc.2009.04.003. Epub 2009 Aug 3. Enferm Infecc Microbiol Clin. 2010. PMID: 19647900 Spanish.
Present-day treatment of tuberculosis and latent tuberculosis infection.
Pérez-Camacho I, Rivero-Juárez A, Kindelán JM, Rivero A. Pérez-Camacho I, et al. Among authors: kindelan jm. Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:41-6. doi: 10.1016/S0213-005X(11)70017-9. Enferm Infecc Microbiol Clin. 2011. PMID: 21420566 Review.
New targets and new drugs in the treatment of HIV.
López-Aldeguer J, Aguirrebengoa K, Arribas JR, Esté JA, Kindelán JM. López-Aldeguer J, et al. Among authors: kindelan jm. Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:25-40. Enferm Infecc Microbiol Clin. 2005. PMID: 16373002 Review. English, Spanish.
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].
Iribarren JA, Labarga P, Rubio R, Berenguer J, Miró JM, Antela A, González J, Moreno S, Arrizabalaga J, Chamorro L, Clotet B, Gatell JM, López-Aldeguer J, Martínez E, Polo R, Tuset M, Viciana P, Santamaría JM, Kindelán JM, Ribera E, Segura F; Grupo de Estudio de Sida; Consejo Asesor Clínico del Plan Nacional sobre el Sida del Ministerio de Sanidad y Consumo. Iribarren JA, et al. Among authors: kindelan jm. Enferm Infecc Microbiol Clin. 2004 Dec;22(10):564-642. doi: 10.1157/13069520. Enferm Infecc Microbiol Clin. 2004. PMID: 15596051 Spanish.
[Lumbar tumor in a patient with AIDS].
Moreno J, Rivero A, Vidal E, Castón JJ, Natera C, de La Torre J, Kindelán JM. Moreno J, et al. Among authors: kindelan jm. Enferm Infecc Microbiol Clin. 2002 Feb;20(2):90-1. doi: 10.1016/s0213-005x(02)72749-3. Enferm Infecc Microbiol Clin. 2002. PMID: 11886680 Spanish. No abstract available.
Tuberculosis treatment adherence and fatality in Spain.
Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, Blanquer R, Casals M; Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE). Caylà JA, et al. Respir Res. 2009 Dec 1;10(1):121. doi: 10.1186/1465-9921-10-121. Respir Res. 2009. PMID: 19951437 Free PMC article. Clinical Trial.
58 results